Deep Origin Introduces Novel Virtual Screening Architecture; Achieves 100-fold Hit Rate Jump on Challenging Target

In a blind test, Deep Origin’s model placed AstraZeneca's oral PCSK9 inhibitor at an unexpected pocket months before a crystal structure that ...